Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/13/2012US20120316223 MODULATION OF pre-mRNA USING SPLICE MODULATING OLIGONUCLEOTIDES AS THERAPEUTIC AGENTS IN THE TREATMENT OF DISEASE
12/13/2012US20120316222 NOVEL RNAi THERAPEUTIC FOR TREATMENT OF HEPATITIS C INFECTION
12/13/2012US20120316221 Compositions and their uses directed to il-4r alpha
12/13/2012US20120316219 Modulation of apolipoprotein(a) expression
12/13/2012US20120316218 SMALL NON-CODING REGULARTORY RNA's and METHODS FOR THEIR USE
12/13/2012US20120316217 combination for the treatment of osteoarthritis
12/13/2012US20120316216 Pyrrolidine substitute flavones for the treatment of inflammatory disorders
12/13/2012US20120316215 Compositions and methods for treating metabolic disorders
12/13/2012US20120316214 Synthesis process, and crystalline form of 4-benzamide hydrochloride and pharmaceutical compositions containing it
12/13/2012US20120316213 Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea
12/13/2012US20120316212 Amino alcohol derivatives and their therapeutic activities
12/13/2012US20120316211 Diagnostic Methods for Assessing Risk of Chagas Disease and Heart Failure
12/13/2012US20120316210 Topical antiparasitic formulations
12/13/2012US20120316209 Diagnostic assay for trypanosoma cruzi infection
12/13/2012US20120316208 Inhibitors of udp-galactopyranose mutase thwart mycobacterial growth
12/13/2012US20120316207 Selective glycosidase inhibitors and uses thereof
12/13/2012US20120316204 Compounds and compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
12/13/2012US20120316203 Compositions and Methods for Inhibition of Cancers
12/13/2012US20120316202 Compounds which have activity at M1 receptor and their uses in medicine
12/13/2012US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/13/2012US20120316200 Pyridone derivatives
12/13/2012US20120316199 Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
12/13/2012US20120316198 Hydrazone and diacyl hydrazine compounds and methods of use
12/13/2012US20120316197 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
12/13/2012US20120316196 Compounds Which Have Activity at M1 Receptor and Their Uses in Medicine
12/13/2012US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors
12/13/2012US20120316194 Apoptosis signal-regulating kinase 1 inhibitors
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316192 Substituted indolo [2,3-a] quinolizines
12/13/2012US20120316191 Peripheral Opioid Receptor Antagonists and Uses Thereof
12/13/2012US20120316190 Modulation of Cell Barrier Dysfunction
12/13/2012US20120316189 Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed respiratory illness
12/13/2012US20120316188 Preparation of 4-amino-thiazoles and 3-amino-1,2,4-thiadiazoles and their use as allosteric modulators of metabotropic glutamate receptors
12/13/2012US20120316187 Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
12/13/2012US20120316186 Deazapurines useful as inhibitors of janus kinases
12/13/2012US20120316185 Cyclohexyl Amide Derivatives as CRF Receptor Antagonists
12/13/2012US20120316183 Novel solvates of methylcarbamate
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316181 Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds
12/13/2012US20120316180 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316179 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
12/13/2012US20120316178 Piperazines as antimalarial agents
12/13/2012US20120316177 Extended release preparation
12/13/2012US20120316176 DERIVATIVES OF 7,8-DIHYDRO-1H-IMIDAZO[2,1-b] PURIN-4(5H)-ONE and METHODS OF USE THEREOF
12/13/2012US20120316175 Solid state forms of sitagliptin salts
12/13/2012US20120316174 Disubstituted phthalazine hedgehog pathway antagonists
12/13/2012US20120316173 Compounds which modulate the cb2 receptor
12/13/2012US20120316172 Pyrazole derivatives
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/13/2012US20120316170 Imidazole Derivative
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316167 Secondary 8-hydroxyquinoline-7-carboxamide derivatives
12/13/2012US20120316166 Hetarylaminonaphthyridines
12/13/2012US20120316165 Substituted benzamide derivatives
12/13/2012US20120316164 Method for inhibiting the growth of cancer stem cells
12/13/2012US20120316163 Pyrazolo Piperidine Derivatives as NADPH Oxidase Inhibitors
12/13/2012US20120316162 Piperidine and piperazine derivatives
12/13/2012US20120316161 Novel antiviral compounds
12/13/2012US20120316160 Xinafoate salt of n4-(2,2-difluoro-4h-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine
12/13/2012US20120316159 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
12/13/2012US20120316158 Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof
12/13/2012US20120316156 [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
12/13/2012US20120316155 Imidazole-2,4-Dione Inhibitors of Casein Kinase 1
12/13/2012US20120316154 Fused tricyclic compounds for the treatment of inflammatory disorders
12/13/2012US20120316153 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
12/13/2012US20120316152 Substituted isoquinolineand isoquinolinone derivatives
12/13/2012US20120316151 Triazolones as fatty acid synthase inhibitors
12/13/2012US20120316150 Amide compounds useful in therapy
12/13/2012US20120316149 Heterocyclic sulfonamide derivatives
12/13/2012US20120316148 Compositions and Methods for Modulating a Kinase
12/13/2012US20120316147 Novel pyridine derivatives
12/13/2012US20120316146 Anaesthetic formulation
12/13/2012US20120316145 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzylidene derivatives, methods for the production thereof and use thereof for treating diseases
12/13/2012US20120316144 Antifungal agent
12/13/2012US20120316143 Ophthalmic composition
12/13/2012US20120316142 Quinolinone derivatives and their pharmaceutical compositions
12/13/2012US20120316141 Method for providing neuroprotection from spinal muscular atrophy
12/13/2012US20120316140 Analgesic composition and method of making the same
12/13/2012US20120316139 Anti-inflammatory compounds and uses thereof
12/13/2012US20120316138 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases
12/13/2012US20120316137 Methods and Compositions for Treating Cancer
12/13/2012US20120316136 Treatment of respiratory disorders using trpa1 antagonists
12/13/2012US20120316135 Compounds for Inhibiting Cell Proliferation in EGFR-Driven Cancers
12/13/2012US20120316134 Anaesthetic composition
12/13/2012US20120316133 Aqueous iron carbohydrate complexes, their production and medicaments containing them
12/13/2012US20120316132 Pharmaceutical oral dosage form containing a synthetic oligosaccharide
12/13/2012US20120316131 Stable Hyaluronan/Steroid Formulation
12/13/2012US20120316130 Compositions and methods for treating estrogen-dependent diseases and conditions
12/13/2012US20120316129 Liquid dressing containing chitosan derivative and preparation method thereof
12/13/2012US20120316128 Citicoline for the treatment of glaucoma and ocular hypertension
12/13/2012US20120316127 Method of manufacturing coating agent for drug releasing stent and coating agent for drug releasing stent manufactured thereby
12/13/2012US20120316126 Compounds for the Treatment of Hepatitis C
12/13/2012US20120316125 Aminoglycosides: synthesis and use as antifungals
12/13/2012US20120316123 Dietary supplement composition of citrus derivatives
12/13/2012US20120316122 Pharmaceutical compositions for combating thrombotic diseases and their preparation and uses
12/13/2012US20120316121 Materials and Methods for Modulating Arginine Metabolism
12/13/2012US20120316111 BMP-2 Upregulating Compounds For Healing Bone Tissue And Screening Methods For Selecting Such Compounds
12/13/2012US20120316110 Injectable Cross-Linked Polymeric Preparations and Uses Thereof
12/13/2012US20120316108 Phospholipid depot
1 ... 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 ... 7860